德国北莱茵-威斯特法伦州肠球菌抗生素耐药性调查。
Survey of antibiotic resistance among enterococci in North Rhine-Westphalia, Germany.
作者信息
Reinert R R, Conrads G, Schlaeger J J, Werner G, Witte W, Lütticken R, Klare I
机构信息
National Reference Center for Streptococci, Institute of Medical Microbiology, University Hospital Aachen, D-52057 Aachen, Germany.
出版信息
J Clin Microbiol. 1999 May;37(5):1638-41. doi: 10.1128/JCM.37.5.1638-1641.1999.
Abstract
A surveillance study on antibiotic resistance of enterococcal isolates (n = 730) was carried out in North Rhine-Westphalia, Germany, in 1997. Resistance rates to ampicillin (7.4%), high-level gentamicin (15.0%), high-level streptomycin (27.9%), ciprofloxacin (37.9%), vancomycin (1.5%), and teicoplanin (1.5%) were determined. All vancomycin-resistant enterococci (VRE) carried the vanA gene. SmaI and ApaI macrorestriction patterns indicated an intra- and interhospital spread of VRE.
摘要
1997年，在德国北莱茵 - 威斯特法伦州开展了一项针对肠球菌分离株（n = 730）抗生素耐药性的监测研究。测定了对氨苄西林（7.4%）、高水平庆大霉素（15.0%）、高水平链霉素（27.9%）、环丙沙星（37.9%）、万古霉素（1.5%）和替考拉宁（1.5%）的耐药率。所有耐万古霉素肠球菌（VRE）均携带vanA基因。SmaI和ApaI酶切宏限制图谱表明VRE在医院内和医院间传播。
相似文献
1
Survey of antibiotic resistance among enterococci in North Rhine-Westphalia, Germany.
J Clin Microbiol. 1999 May;37(5):1638-41. doi: 10.1128/JCM.37.5.1638-1641.1999.
2
vanA Gene Harboring Enterococcal and Non-enterococcal Isolates Expressing High Level Vancomycin and Teicoplanin Resistance Reservoired in Surface Waters.
Bull Environ Contam Toxicol. 2017 May;98(5):712-719. doi: 10.1007/s00128-016-1955-8. Epub 2016 Oct 21.
3
Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS).
J Antimicrob Chemother. 2003 Sep;52(3):382-8. doi: 10.1093/jac/dkg352. Epub 2003 Jul 29.
4
Emergence of the vanA genotype among Enterococcus gallinarum isolates colonising the intestinal tract of patients in a university hospital in Rio de Janeiro, Brazil.
Int J Antimicrob Agents. 2009 Mar;33(3):211-5. doi: 10.1016/j.ijantimicag.2008.08.018. Epub 2008 Nov 17.
5
Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
Acta Microbiol Immunol Hung. 2011 Sep;58(3):219-26. doi: 10.1556/AMicr.58.2011.3.5.
6
Emergence of High-level Gentamicin Resistance among Clinical Isolates from Burn Patients in South-west of Iran: Vancomycin Still Working.
Pol J Microbiol. 2018;67(4):401-406. doi: 10.21307/pjm-2018-043.
7
Emergence of vanA gene among vancomycin-resistant enterococci in a tertiary care hospital of North - East India.
Indian J Med Res. 2016 Mar;143(3):357-61. doi: 10.4103/0971-5916.182627.
8
Characterization of Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium Isolated from Fresh Produces and Human Fecal Samples.
Foodborne Pathog Dis. 2017 Apr;14(4):195-201. doi: 10.1089/fpd.2016.2188. Epub 2017 Mar 27.
9
Vancomycin-resistant enterococci in rooks (Corvus frugilegus) wintering throughout Europe.
Environ Microbiol. 2013 Feb;15(2):548-56. doi: 10.1111/1462-2920.12002. Epub 2012 Nov 1.
10
Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates.
J Clin Microbiol. 1998 Aug;36(8):2187-90. doi: 10.1128/JCM.36.8.2187-2190.1998.
引用本文的文献
1
The emerging epidemiology of VRE in Canada: results of the CNISP Passive Reporting Network, 1994 to 1998.
Can J Infect Dis. 2001 Nov;12(6):364-70. doi: 10.1155/2001/424608.
2
Vancomycin-resistant enterococci in Canada revisited.
Can J Infect Dis. 2000 May;11(3):127-31. doi: 10.1155/2000/626047.
3
Clonal spread of a vancomycin-resistant Enterococcus faecium strain among bloodstream-infecting isolates in Italy.
J Clin Microbiol. 2005 Apr;43(4):1575-80. doi: 10.1128/JCM.43.4.1575-1580.2005.
4
Influence of transferable genetic determinants on the outcome of typing methods commonly used for Enterococcus faecium.
J Clin Microbiol. 2003 Apr;41(4):1499-506. doi: 10.1128/JCM.41.4.1499-1506.2003.
本文引用的文献
1
A database system for fragment patterns of genomic DNA of Staphylococcus aureus.
Zentralbl Bakteriol. 1998 Jan;287(1-2):105-16. doi: 10.1016/s0934-8840(98)80154-0.
2
Arrangement of the vanA gene cluster in enterococci of different ecological origin.
FEMS Microbiol Lett. 1997 Oct 1;155(1):55-61. doi: 10.1111/j.1574-6968.1997.tb12685.x.
3
[Antibiotic resistance of enterococci in Germany].
Med Klin (Munich). 1997 Aug 15;92(8):464-8, 505. doi: 10.1007/BF03044913.
4
Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community.
Microb Drug Resist. 1995 Fall;1(3):265-72. doi: 10.1089/mdr.1995.1.265.
5
Environmental strains of Enterococcus faecium with inducible high-level resistance to glycopeptides.
FEMS Microbiol Lett. 1993 Jan 1;106(1):23-9. doi: 10.1111/j.1574-6968.1993.tb05930.x.
6
Increasing problems in the therapy of enterococcal infections.
Eur J Clin Microbiol Infect Dis. 1993 Jun;12(6):409-12. doi: 10.1007/BF01967433.
7
Phenotypic identification of the genus Enterococcus and differentiation of phylogenetically distinct enterococcal species and species groups.
J Appl Bacteriol. 1993 Nov;75(5):399-408. doi: 10.1111/j.1365-2672.1993.tb02794.x.
8
Characterization of glycopeptide-resistant enterococci from U.S. hospitals.
Antimicrob Agents Chemother. 1993 Nov;37(11):2311-7. doi: 10.1128/AAC.37.11.2311.
9
Comparison of high-level gentamicin-resistant Enterococcus faecium isolates from different continents.
Antimicrob Agents Chemother. 1993 Apr;37(4):681-4. doi: 10.1128/AAC.37.4.681.
10
vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry.
FEMS Microbiol Lett. 1995 Jan 15;125(2-3):165-71. doi: 10.1111/j.1574-6968.1995.tb07353.x.
Zotero 插件